PLEXISION, INC.
PITSBURG, PA

Plexision, Inc. is a pioneering healthcare company specializing in the development of cellular biomarkers for personalized diagnosis and drug development within solid organ transplantation and immunological disorders. Established as part of the innovative efforts to enhance transplant diagnostics, Plexision's flagship patented product, Pleximmune®, offers critical testing services through its CLIA-certified laboratory located in Pittsburgh. At its core, Plexision customizes antigen-specific and non-specific cell-based assays, simulating disease conditions to generate personalized test outputs. This approach enables healthcare professionals to make informed decisions regarding transplant recipients and advance drug development efforts across various categories. Leadership at Plexision comprises esteemed figures such as Rajeev Sindhi, a 20-year veteran in the healthcare industry serving as Co-founder, Chief Executive Officer, Chairman of its Board, and Managing Director of the Sandor group in India. Additionally, Rakesh Sindhi contributes his expertise as a transplant surgeon, Co-founder, Chief Scientific Officer, Professor of Surgery at the University of Pittsburgh, where he developed the scientific basis for Plexision's technologies under exclusive licensing. The company's operational expertise benefits from Ashok Reddy, Director of Operations and a long-time colleague with three decades of senior management experience. The diverse background includes operations in IT healthcare sectors and past roles such as Senior Vice-President at Infinite Computer Solutions. With a registered status in Florida (F16000003024) and headquartered with an address at 22485 Castle Oak Road, Clarksburg, MD, Plexision is incorporated under the company type 'FORP' on July 7, 2016. Its mailing contacts are accessible via phone numbers: (855) 753-9474; (412) 224-2776. For further information and insights into their state-of-the-art services, visit their website at plexision.com.